---
title: "TGTX SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for TG Therapeutics (TGTX), with links to the SEC filings."
url: "https://tradytics.com/research/TGTX/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=TGTX&v=stock-11994860"
---

# TGTX financial statements and SEC filings

## TGTX annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $616.29M | $123.32M | $447.18M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2024-12-31 | $329.00M | $41.93M | $23.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2023-12-31 | $233.66M | $20.63M | $12.67M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2022-12-31 | $2.79M | -$218.32M | -$223.81M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774925005908/0001437749-25-005908-index.htm) |
| 2021-12-31 | $6.69M | -$344.77M | -$348.10M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774924006144/0001437749-24-006144-index.htm) |
| 2020-12-31 | $152.00K | -$273.59M | -$279.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000155837023002610/0001558370-23-002610-index.htm) |

## TGTX annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $1.06B | $415.23M | $648.02M | [10-Q](https://www.sec.gov/Archives/edgar/data/1001316/000162828026072257/0001628280-26-072257-index.htm) |
| 2024-12-31 | $577.69M | $355.33M | $222.36M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2023-12-31 | $329.59M | $169.09M | $160.50M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774925005908/0001437749-25-005908-index.htm) |
| 2022-12-31 | $193.57M | $134.99M | $58.59M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774924006144/0001437749-24-006144-index.htm) |
| 2021-12-31 | $379.63M | $142.48M | $237.15M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000155837023002610/0001558370-23-002610-index.htm) |
| 2020-12-31 | $625.64M | $106.29M | $519.35M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000155837022002617/0001558370-22-002617-index.htm) |

## TGTX annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$24.77M | -$214.00K | -$89.73M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2024-12-31 | -$40.52M | -$45.00K | $128.53M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2023-12-31 | -$31.41M | $0.00 | $72.70M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/0001437749-26-006133-index.htm) |
| 2022-12-31 | -$176.17M | -$14.00K | -$391.00K | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774925005908/0001437749-25-005908-index.htm) |
| 2021-12-31 | -$295.63M | -$401.00K | $41.42M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000143774924006144/0001437749-24-006144-index.htm) |
| 2020-12-31 | -$214.51M | -$357.00K | $679.83M | [10-K](https://www.sec.gov/Archives/edgar/data/1001316/000155837023002610/0001558370-23-002610-index.htm) |

- [TGTX stock research](https://tradytics.com/research/TGTX)
- [TGTX financial summary](https://tradytics.com/research/TGTX/financials)
- [Read the data without JavaScript](https://tradytics.com/research/TGTX/fundamentals?snapshot=1)
